E
Y. Naganawa et al.
Letter
Synlett
(9) For selected recent examples on the use of other Michael
accepters, see: (a) Zhu, Q.; Lu, Y. Angew. Chem. Int. Ed. 2010, 49,
7753. (b) Wang, T.; Yao, W.; Zhong, F.; Pang, G. H.; Lu, Y. Angew.
Chem. Int. Ed. 2014, 53, 2964. (c) Zou, L.; Bao, X.; Ma, Y.; Song,
Y.; Qu, J.; Wang, B. Chem. Commun. 2014, 50, 5760. (d) Zhang, T.;
Cheng, L.; Hameed, S.; Liu, L.; Wanga, D.; Chen, Y.-J. Chem.
Commun. 2011, 47, 6644. (e) Liao, Y.-H.; Liu, X.-L.; Wu, Z.-J.;
Cun, L.-F.; Zhang, X.-M.; Yuan, W.-C. Org. Lett. 2010, 12, 2896.
(f) Li, X.; Luo, S.; Cheng, J.-P. Chem. Eur. J. 2010, 16, 14290.
(g) Siau, W.-Y.; Li, W.; Xue, F.; Ren, Q.; Wu, M.; Sun, S.; Guo, H.;
Jiang, X.; Wang, J. Chem. Eur. J. 2012, 18, 9491.
(10) (a) Naganawa, Y.; Namba, T.; Aoyama, T.; Shoji, K.; Nishiyama,
H. Chem. Commun. 2014, 50, 13224. (b) Naganawa, Y.; Namba,
T.; Kawagishi, M.; Nishiyama, H. Chem. Eur. J. 2015, 21, 9319.
(c) Naganawa, Y.; Komatsu, H.; Nishiyama, H. Chem. Lett. 2015,
44, 1652. (d) Naganawa, Y.; Aoyama, T.; Nishiyama, H. Org.
Biomol. Chem. 2015, 13, 11499.
this paper. The data can be obtained free of charge from The
Cambridge
Crystallographic
Data
Centre
via
(14) We also tested this N-methyloxycarbonyl-3-phenyloxindole in
the enantioselective hydroxylation reaction with Davis’ oxaziri-
dine in the presence of Cu(II) complex of (S)-1b (ref. 10d). We
obtained the corresponding hydroxylated product in 89% yield
and with 86% ee. This was the slight lower ee than that of the
product in the reaction of N-Boc-3-phenyloxidole 2a (85% yield,
95% ee).
(15) (a) Girard, C.; Kagan, H. B. Angew. Chem. Int. Ed. 1998, 37, 2922.
(b) Blackmond, D. G. Acc. Chem. Res. 2000, 33, 402.
(16) We observed chiral Ni(II) complex of (S)-1c and Ni(OAc)2 in
molecular ratio of 1:1 by ESI-MS analysis. At the same time, we
did not confirm the other complex of (S)-1c and Ni(OAc)2 in
molecular ratio of 2:1. For details, see Supporting Information.
(17) General Experimental Procedures for Enantioselective
Michael Addition
(11) Procedure for the Synthesis of Ligand (S)-1c
A solution of phen (0.90 g, 5 mmol) in THF (20 mL) was cooled
to –78 °C, and PhLi (1.5 equiv, 7.5 mmol) was added dropwise.
The resulting black suspension was warmed up to room tem-
perature. After stirring overnight, the reaction mixture was
poured into water, and the aqueous phase was extracted with
EtOAc. The organic phase was dried over anhydrous MgSO4 and
concentrated under reduced pressure. To a stirred solution of
the crude product in EtOAc, MnO2 was added at room tempera-
ture. The black suspension was kept stirred at 60 °C. After stir-
ring for 6 h, the reaction mixture was filtered by Celite and con-
centrated under reduced pressure. Purification by column
chromatography on silica gel afforded 2-Ph-phen in 58% yield.
A solution of (S)-5 (780 mg, 2 mmol) in THF (10 mL) was cooled
to –78 °C, and n-BuLi (1.1 equiv, 2.2 mmol) was added drop-
wise. After stirring for 1 h, 2-Ph-phen (1.1 equiv, 2.2 mmol) was
added dropwise. After stirring overnight, the reaction mixture
was poured into water, and the aqueous phase was extracted
with EtOAc. The organic phase was dried over anhydrous MgSO4
and concentrated under reduced pressure. To a stirred solution
of the crude product in EtOAc, MnO2 was added at room tem-
perature. The black suspension was kept stirred at 60 °C. After
stirring for 6 h, the reaction mixture was filtrated by Celite and
concentrated under reduced pressure. The residue was added
MeOH and concd HCl, and heated to 60 °C. After stirring 12 h,
the reaction mixture was poured into aq NaHCO3 and the
aqueous phase was extracted with EtOAc. Purification by
column chromatography on silica gel afforded (S)-1c as a yellow
powder in 40% yield.
To a mixture of (S)-1c (7.2 mg, 12.0 μmol) and Ni(II) salts (10.0
μmol) in a Schlenk tube under Ar atmosphere, dry CH2Cl2 (0.5
mL) was added at room temperature. After stirring for 30 min at
40 °C, the reaction mixture was cooled to 25 °C, and then oxin-
dole 2 (0.1 mmol) was added at one portion to the mixture.
After stirring another 30 min, MVK (25 μL, 0.30 mmol) was sub-
jected at one portion to the mixture and stirred at the 25 °C, the
catalyst was removed by passing through short column chroma-
tography on silica gel (eluting CHCl3), and the solvent was evap-
orated. The residue was purified by column chromatography
(eluting hexane–EtOAc or toluene–EtOAc) to give the desired
products (R)-4.
Compound 4e: IR (KBr): 3414, 1982, 1764, 1732, 1619, 1480,
1465, 1412, 1395, 1371, 1325, 1253, 1148, 1072, 1017 cm–1. 1H
NMR (300 MHz, CDCl3): δ = 7.97 (d, J = 10.2 Hz, 1 H), 7.58–7.55
(m, 2 H), 7.46–7.38 (m, 2 H), 7.28–7.15 (m, 3 H), 2.80–2.71 (m, 1
H), 2.55–2.31 (m, 2 H), 2.11–2.00 (m, 4 H), 1.64 (s, 9 H) ppm. 13
C
NMR (75 MHz, CDCl3): δ = 207.0, 176.2, 149.3, 143.5, 140.1,
130.3 (q, JC–F = 32.3 Hz), 129.7, 129.4, 127.7, 125.9 (q, JC–F = 3.7
Hz), 125.3, 124.9, 123.9 (q, JC–F = 228.3 Hz), 115.8, 85.3, 56.1,
38.7, 32.0, 30.3, 28.3 ppm. HRMS–FAB: m/z calcd for
C
24H24O4NF3 [M + Na]+: 470.1550; found: 470.1534. [α]D21 +69.0
(c 0.50, CHCl3). The enantiomeric purity of the product was
determined by HPLC analysis (Daicel CHIRALPAK AD-H,
hexane–i-PrOH = 15:1, flow rate = 1.0 mL min–1): tR (minor) =
6.8 min; tR (major) = 9.8 min; ee 65%.
Compound 4j: IR (KBr): 3441, 1979, 1759, 1729, 1511, 1490,
1415, 1511, 1450, 1415, 1369, 1339, 1254, 1153, 1116, 1062,
1
Compound (S)-1c: IR (KBr): 3861, 3450, 3053, 1621, 1591, 1549,
1011 cm–1. H NMR (300 MHz, CDCl3): δ = 7.90 (d, J = 8.4 Hz, 1
1
1497, 1469, 1438, 1360, 1306, 1204, 1151, 1106 cm–1. H NMR
H), 7.29–7.18 (m, 5 H), 7.04 (d, J = 2.1 Hz, 1 H), 2.86–2.78 (m, 1
H), 2.54–2.12 (m, 9 H), 2.11 (s, 3 H), 1.72 (s, 9 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 207.2, 176.9, 149.4, 137.6, 137.5. 136.8,
134.6, 130.8, 129.6, 129.3, 127.0, 125.2, 115.3, 84.7, 56.1, 39.3,
32.0, 30.6, 28.6, 21.7, 21.5 ppm. HRMS–FAB: m/z calcd for
(300 MHz, CDCl3): δ = 8.28 (m, 3 H), 8.14 (d, J = 4.4 Hz, 1 H),
8.05–7.94 (m, 5 H), 7.82–7.79 (m, 1 H), 7.65 (d, J = 4.1 Hz, 1 H),
7.56–7.44 (m, 4 H), 7.37–7.18 (m, 9 H), 7.12–7.07 (m, 2 H),
7.03–7.00 (m, 1 H) (phenolic OH was not observed) ppm. 13C
NMR (75 MHz, CDCl3): δ = 156.8, 156.6, 156.1, 143.9, 143.4,
142.4, 140.7, 138.3, 137.4, 136.6, 136.1, 133.6, 133.3, 132.8,
129.9, 129.4, 129.1, 128.9, 128.6, 128.1, 127.9, 127.8, 127.7,
127.6, 127.4, 127.4, 126.85, 126.82, 126.5, 126.3, 126.0, 125.7,
125.2, 122.9, 121.5, 121.1, 119.6, 119.2 ppm. HRMS–FAB: m/z
C
25H29NO4 [M + Na]+: 430.1994; found: 430.1989. [α]D21 +64.2 (c
0.10, CHCl3). The enantiomeric purity of the product was deter-
mined by HPLC analysis (Daicel CHIRALPAK AD-H, hexane–i-
PrOH = 90:10, flow rate = 1.0 mL min–1): tR (minor) = 8.0 min; tR
(major) = 13.8 min; ee 80%.
21
calcd for C24H29N2O [M + H]+: 601.2280; found: 601.2284. [α]D
Compound 4k: IR (KBr): 3413, 2980, 2839, 1766, 1731, 1608,
1
–131.9 (c 0.50, CHCl3).
1580, 1513, 1483, 1394, 1347, 1254, 1146, 1033 cm–1. H NMR
(12) Jakobsen, S.; Tilset, M. Tetrahedron Lett. 2011, 52, 3072.
(13) Crystallographic data obtained for (S)-1c had been deposited
with the Cambridge Crystallographic Data Centre. CCDC
1455175 contains the supplementary crystallographic data for
(300 MHz, CDCl3): δ = 7.94 (dd, J = 8.7, 4.5 Hz, 1 H), 7.21–7.18
(m, 2 H), 7.11–7.04 (m, 1 H), 6.91–6.83 (m, 3 H), 3.78 (s, 3 H),
2.79–2.65 (m, 1 H), 2.43–2.32 (m, 2 H), 2.15–2.08 (m, 1 H), 2.05
(s, 3 H), 1.62 (s, 9 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 207.1,
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, A–F